RAMP is a structured risk assessment and management solution designed to ensure that only protocol-eligible patients are enrolled in late-phase clinical trials. By standardising eligibility assessments and enabling controlled medical review prior to enrolment, RAMP helps prevent protocol deviations, enhance patient safety, and protect data integrity across global studies.
Prevents enrolment of ineligible patients through rule-based eligibility checks aligned with the study protocol.
Protects patient wellbeing by enforcing strict eligibility criteria and controlled screening decisions.
Reduces eligibility-related protocol deviations and minimises downstream rework.
Ensures uniform eligibility decisions across sites and regions, eliminating variability from manual interpretation.
Strengthens data quality by ensuring eligibility information is accurate, complete, and traceable.
Maintains audit-ready documentation to support transparent and confident regulatory inspections.
